Macrocycles for the treatment of autoimmune disease

CR20260110APending Publication Date: 2026-06-15F HOFFMANN LA ROCHE & CO AG

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: CR202600110
Authority / Receiving Office: CR · CR
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2024-09-24
Filing Date: 2024-09-24
Publication Date: 2026-06-15

Application Information

Patent Timeline

24 Sep 2024

Priority

24 Sep 2024

Application

CR202600110

15 Jun 2026

Publication

CR20260110A

IPC: A61P35/00; A61K31/519; A61P3/00; A61P9/00; A61P25/00; A61P27/02; A61P29/00; A61P37/00; C07D519/00

CPC: C07D519/00; A61P35/00; A61P37/00; A61P29/00; A61P25/00; A61P3/00; A61P9/00; A61P27/02

Inventors: WU Yao; ZHU Wei

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The application relates to compounds of formula (I) which act as antagonists of STING useful for the treatment of autoimmune diseases, inflammatory diseases, neurological disorders, metabolic diseases, cardiovascular diseases, ocular diseases, or selective types of cancer where overexpression or activation of STING is implicated.

Need to check novelty before this filing date? Find Prior Art